U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07080944) titled 'Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC' on July 15.
Brief Summary: This study will prospectively determine the feasibility and oncological safety of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) in inflammatory breast cancer patients traditionally considered ineligible for SLNB due to locally advanced cancer with skin/chest wall involvement (cT4d) and heavy nodal burden at presentation (cN1/N2). We will also assess the identification rate of sentinel lymph-node (SLN) (using single tracer mapping) after NACT in this patient population. Finally, we will determine the long-term outcom...